These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

778 related articles for article (PubMed ID: 33585689)

  • 1. Effectiveness of glucocorticoids in patients hospitalized for severe SARS-CoV-2 pneumonia.
    Pascual Pareja JF; García-Caballero R; Soler Rangel L; Vázquez-Ronda MA; Roa Franco S; Navarro Jiménez G; Moreno Palanco MA; González-Ruano P; López-Menchaca R; Ruíz-Seco P; Pagán Muñoz B; Gómez Gómez A; Pérez-Monte B; Fuerte Martínez R; Valle López JL; Muñoz Blanco A; Rábago Lorite I; Martínez Martín P; Serralta San Martín G; Gómez-Cerezo JF;
    Med Clin (Engl Ed); 2021 Mar; 156(5):221-228. PubMed ID: 33585689
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effectiveness of glucocorticoids in patients hospitalized for severe SARS-CoV-2 pneumonia.
    Pascual Pareja JF; García-Caballero R; Soler Rangel L; Vázquez-Ronda MA; Roa Franco S; Navarro Jiménez G; Moreno Palanco MA; González-Ruano P; López-Menchaca R; Ruíz-Seco P; Pagán Muñoz B; Gómez Gómez A; Pérez-Monte B; Fuerte Martínez R; Valle López JL; Muñoz Blanco A; Rábago Lorite I; Martínez Martín P; Serralta San Martín G; Gómez-Cerezo JF;
    Med Clin (Barc); 2021 Mar; 156(5):221-228. PubMed ID: 33380371
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
    Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
    Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Outpatient treatment of COVID-19 with steroids in the phase of mild pneumonia without the need for admission as an opportunity to modify the course of the disease: A structured summary of a randomised controlled trial.
    Saiz-Rodríguez M; Peña T; Lázaro L; González Á; Martínez A; Cordero JA; Vicente JT; Richard F; Coma MJ; de Frutos M; Labrador J; Pueyo A
    Trials; 2020 Jul; 21(1):632. PubMed ID: 32646502
    [TBL] [Abstract][Full Text] [Related]  

  • 5. "Effect of calcifediol treatment and best available therapy versus best available therapy on intensive care unit admission and mortality among patients hospitalized for COVID-19: A pilot randomized clinical study".
    Entrenas Castillo M; Entrenas Costa LM; Vaquero Barrios JM; Alcalá Díaz JF; López Miranda J; Bouillon R; Quesada Gomez JM
    J Steroid Biochem Mol Biol; 2020 Oct; 203():105751. PubMed ID: 32871238
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of COVID-19 pneumonia with glucocorticoids (CORTIVID): a structured summary of a study protocol for a randomised controlled trial.
    Les Bujanda I; Loureiro-Amigo J; Bastons FC; Guerra IE; Sánchez JA; Murgadella-Sancho A; Rey RG; López JL; Álvarez JS
    Trials; 2021 Jan; 22(1):43. PubMed ID: 33430891
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High dose dexamethasone treatment for Acute Respiratory Distress Syndrome secondary to COVID-19: a structured summary of a study protocol for a randomised controlled trial.
    Maskin LP; Olarte GL; Palizas F; Velo AE; Lurbet MF; Bonelli I; Baredes ND; Rodríguez PO
    Trials; 2020 Aug; 21(1):743. PubMed ID: 32843098
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of immunosuppressants on the prognosis of SARS-CoV-2 infection.
    Ward D; Gørtz S; Thomson Ernst M; Andersen NN; Kjær SK; Hallas J; Christensen S; Fynbo Christiansen C; Bastrup Israelsen S; Benfield T; Pottegård A; Jess T
    Eur Respir J; 2022 Apr; 59(4):. PubMed ID: 34475227
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multi-centre, three arm, randomized controlled trial on the use of methylprednisolone and unfractionated heparin in critically ill ventilated patients with pneumonia from SARS-CoV-2 infection: A structured summary of a study protocol for a randomised controlled trial.
    Busani S; Tosi M; Mighali P; Vandelli P; D'Amico R; Marietta M; Forfori F; Donati A; Cinnella G; De Monte A; Pasero D; Bellani G; Tascini C; Foti G; Ranieri M; Girardis M
    Trials; 2020 Aug; 21(1):724. PubMed ID: 32807241
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dexamethasone vs methylprednisolone high dose for Covid-19 pneumonia.
    Pinzón MA; Ortiz S; Holguín H; Betancur JF; Cardona Arango D; Laniado H; Arias Arias C; Muñoz B; Quiceno J; Jaramillo D; Ramirez Z
    PLoS One; 2021; 16(5):e0252057. PubMed ID: 34033648
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interferon-α2b spray inhalation did not shorten virus shedding time of SARS-CoV-2 in hospitalized patients: a preliminary matched case-control study.
    Hao SR; Yan R; Zhang SY; Lian JS; Cai H; Zhang XL; Zheng L; Jia HY; Hu JH; Yu GD; Gu JQ; Ye CY; Jin CL; Lu YF; Xin JJ; Sheng JF; Yang YD
    J Zhejiang Univ Sci B; 2020 Aug.; 21(8):628-636. PubMed ID: 32748578
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High-Dose Prednisone for Treatment of Autoimmune Pancreatitis in a Patient with Coronavirus Disease 2019 (COVID-19) due to Infection with Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2).
    Liaquat H; Shupp B; Kapoor S; Matin A
    Am J Case Rep; 2020 Jul; 21():e926475. PubMed ID: 32692733
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sarilumab versus standard of care for the early treatment of COVID-19 pneumonia in hospitalized patients: SARTRE: a structured summary of a study protocol for a randomised controlled trial.
    Caballero Bermejo AF; Ruiz-Antorán B; Fernández Cruz A; Diago Sempere E; Callejas Díaz A; Múñez Rubio E; Avendaño-Solá C; Ramos Martínez A; Sancho López A;
    Trials; 2020 Sep; 21(1):794. PubMed ID: 32938496
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of α1-Blocker Receipt With 30-Day Mortality and Risk of Intensive Care Unit Admission Among Adults Hospitalized With Influenza or Pneumonia in Denmark.
    Thomsen RW; Christiansen CF; Heide-Jørgensen U; Vogelstein JT; Vogelstein B; Bettegowda C; Tamang S; Athey S; Sørensen HT
    JAMA Netw Open; 2021 Feb; 4(2):e2037053. PubMed ID: 33566109
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glucocorticoids with low-dose anti-IL1 anakinra rescue in severe non-ICU COVID-19 infection: A cohort study.
    Borie R; Savale L; Dossier A; Ghosn J; Taillé C; Visseaux B; Jebreen K; Diallo A; Tesmoingt C; Morer L; Goletto T; Faucher N; Hajouji L; Neukirch C; Phillips M; Stelianides S; Bouadma L; Brosseau S; Ottaviani S; Pluvy J; Le Pluart D; Debray MP; Raynaud-Simon A; Descamps D; Khalil A; Timsit JF; Lescure FX; Descamps V; Papo T; Humbert M; Crestani B; Dieude P; Vicaut E; Zalcman G;
    PLoS One; 2020; 15(12):e0243961. PubMed ID: 33326457
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Factors associated with clinical severity in emergency department patients presenting with symptomatic SARS-CoV-2 infection.
    Newton S; Zollinger B; Freeman J; Moran S; Helfand A; Authelet K; McHarg M; Montano Vargas N; Shesser R; Cohen JS; Cummings DAT; Ma Y; Meltzer AC
    J Am Coll Emerg Physicians Open; 2021 Aug; 2(4):e12453. PubMed ID: 34223443
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Baricitinib improves respiratory function in patients treated with corticosteroids for SARS-CoV-2 pneumonia: an observational cohort study.
    Rodriguez-Garcia JL; Sanchez-Nievas G; Arevalo-Serrano J; Garcia-Gomez C; Jimenez-Vizuete JM; Martinez-Alfaro E
    Rheumatology (Oxford); 2021 Jan; 60(1):399-407. PubMed ID: 33020836
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SARS-CoV-2 Pneumonia in Hospitalized Asthmatic Patients Did Not Induce Severe Exacerbation.
    Grandbastien M; Piotin A; Godet J; Abessolo-Amougou I; Ederlé C; Enache I; Fraisse P; Tu Hoang TC; Kassegne L; Labani A; Leyendecker P; Manien L; Marcot C; Pamart G; Renaud-Picard B; Riou M; Doyen V; Kessler R; Fafi-Kremer S; Metz-Favre C; Khayath N; de Blay F
    J Allergy Clin Immunol Pract; 2020 Sep; 8(8):2600-2607. PubMed ID: 32603901
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Severe Acute Respiratory Syndrome by SARS-CoV-2 Infection or Other Etiologic Agents Among Brazilian Indigenous Population: An Observational Study from the First Year of Coronavirus Disease (COVID)-19 Pandemic.
    Sansone NMS; Boschiero MN; Ortega MM; Ribeiro IA; Peixoto AO; Mendes RT; Marson FAL
    Lancet Reg Health Am; 2022 Apr; 8():100177. PubMed ID: 35018359
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vitamin D Status and SARS-CoV-2 Infection and COVID-19 Clinical Outcomes.
    Chiodini I; Gatti D; Soranna D; Merlotti D; Mingiano C; Fassio A; Adami G; Falchetti A; Eller-Vainicher C; Rossini M; Persani L; Zambon A; Gennari L
    Front Public Health; 2021; 9():736665. PubMed ID: 35004568
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 39.